MKI67 and triple-negative breast carcinoma: As shown in Table 3, patients who responded to NCT were comparable to those who did not respond in terms of age, menstrual status, tumor status, lymph node status, tumor grade, HR status, triple-negative breast cancer (TNBC), P63, Ki67, and Her-2/neu expression (P > 0.05).